NCT06892860View on ClinicalTrials.gov

Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

June 30, 2027

Study Completion Date

December 22, 2027

Conditions
Urinary Bladder Neoplasms
Interventions
DRUG

Avelumab

Avelumab treatment will be given up to a maximum of 2 years from the end of chemotherapy

Trial Locations (3)

Unknown

RECRUITING

Unicancer, Paris

ENROLLING_BY_INVITATION

Adknoma, Madrid

RECRUITING

Barts Health NHS Trust, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER